Flower colour and cytochromes P450

被引:115
|
作者
Tanaka Y. [1 ]
机构
[1] Institute for Advanced Core Technology, Suntory Ltd., Mishima-gun, Osaka 618-8503, 1-1-1, Wakayamadai, Shimamoto-cho
关键词
Anthocyanin; Cyanidin; Cytochrome P450; Delphinidin; Dihydroflavonol; 4-reductase; Flavone; Flavone synthase II; Flavonoid; 3′; 5′-hydroxylase; Flavonoid 3′-hydroxylase; Flavonol hydroxylase; Flower colour; Monooxygenase; Pelargonidin;
D O I
10.1007/s11101-006-9003-7
中图分类号
学科分类号
摘要
Flavonoids are major constituents of flower colour. Plants accumulate specific flavonoids and thus every species often exhibits a limited flower colour range. Three cytochromes P450 play critical roles in the flavonoid biosynthetic pathway. Flavonoid 3′-hydroxylase (F3′H, CYP75B) and flavonoid 3′,5′-hydroxylase (F3′5′H, CYP75A) catalyze the hydroxylation of the B-ring of flavonoids and are necessary to biosynthesize cyanidin-(red to magenta) and delphinidin-(violet to blue) based anthocyanins, respectively. Pelargonidin-based anthocyanins (orange to red) are synthesized in their absence. Some species such as roses, carnations and chrysanthemums do not have violet/blue flower colour due to deficiency of F3′5′H. Successful expression of heterologous F3′5′H genes in roses and carnations results in delphinidin production, causing a novel blue/violet flower colour. Down-regulation of F3′H and F3′5′H genes has yielded orange petunia and pink torenia colour that accumulate pelargonidin-based anthocyanins. Flavone synthase II (CYP93B) catalyzes the synthesis of flavones that contribute to the bluing of flower colour, and modulation of FNSII gene expression in petunia and tobacco changes their flower colour. Extensive engineering of the anthocyanin pathway is therefore now possible, and can be expected to enhance the range of flower colours. © 2006 Springer Science+Business Media B.V.
引用
收藏
页码:283 / 291
页数:8
相关论文
共 50 条
  • [31] Prokaryotic Cytochromes P450 (Review)
    Khmelevtsova, L. E.
    Sazykin, I. S.
    Sazykina, M. A.
    Seliverstova, E. Yu.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2017, 53 (04) : 401 - 409
  • [32] The Role of Cytochromes P450 in Infection
    Stavropoulou, Elisavet
    Pircalabioru, Gratiela G.
    Bezirtzoglou, Eugenia
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [33] Inhibition of cytochromes p450 by isoflavones
    Shebley, M
    Kim, H
    Roberts-Kirchhoff, ES
    FASEB JOURNAL, 2002, 16 (04): : A145 - A146
  • [34] Pharmacophore modeling of cytochromes P450
    de Groot, MJ
    Ekins, S
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (03) : 367 - 383
  • [35] Homology modeling of cytochromes P450
    Dai, R
    Robinson, RC
    Friedman, FK
    BIOPHYSICAL JOURNAL, 1999, 76 (01) : A423 - A423
  • [36] THE CYTOCHROMES P450 AND TOXIC PROCESSES
    LEWIS, D
    MANUFACTURING CHEMIST, 1995, 66 (10): : 35 - &
  • [37] Comparative modelling of cytochromes P450
    Kirton, SB
    Baxter, CA
    Sutcliffe, MJ
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (03) : 385 - 406
  • [38] Cytochromes P450 in the bioactivation of chemicals
    Ioannides, C
    Lewis, DFV
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (16) : 1767 - 1788
  • [39] Cytochromes P450 (P450s): Funereal modifications
    Correia, MA
    FASEB JOURNAL, 1997, 11 (09): : A774 - A774
  • [40] Pig and minipig cytochromes P450 - Response
    Myers, MJ
    Farrell, DE
    Howard, KD
    Kawalek, JC
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (01) : 101 - 102